Defining infection risk of bispecific antibodies for myeloma

被引：0
|
作者：
Hammond, Sarah P. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Div Infect Dis & Hematol Oncol, Boston, MA 02114 USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD ADVANCES | 2024年 / 8卷 / 18期
关键词：
D O I：
10.1182/bloodadvances.2024013813
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4977 / 4978
页数：2
相关论文
共 50 条
  • [1] Bispecific antibodies in myeloma
    Le Grand, Sophie
    Perrot, Aurore
    HEMATOLOGIE, 2021, 27 : 19 - 25
  • [2] Bispecific antibodies in multiple myeloma
    Escure, Guillaume
    Manier, Salomon
    BULLETIN DU CANCER, 2021, 108 (10) : S205 - S212
  • [3] Bispecific Antibodies for the Treatment of Multiple Myeloma
    Scott R. Goldsmith
    Shawn Streeter
    Fahrettin Covut
    Current Hematologic Malignancy Reports, 2022, 17 : 286 - 297
  • [4] Bispecific Antibodies in the Treatment of Multiple Myeloma
    Zhou, Xiang
    Xiao, Xianghui
    Kortuem, Klaus Martin
    Einsele, Hermann
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (02) : 361 - 381
  • [5] Bispecific Antibodies for the Treatment of Multiple Myeloma
    Goldsmith, Scott R.
    Streeter, Shawn
    Covut, Fahrettin
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (06) : 286 - 297
  • [6] Bispecific antibodies in the treatment of multiple myeloma
    Devasia, Anup Joseph
    Chari, Ajai
    Lancman, Guido
    BLOOD CANCER JOURNAL, 2024, 14 (01):
  • [7] Infection rates are high across the multiple myeloma continuum, not just with bispecific antibodies
    Rubinstein, Samuel M.
    Derman, Benjamin A.
    EUROPEAN JOURNAL OF CANCER, 2023, 189
  • [8] Recommendations for Infection Screening and Prophylaxis for Bispecific Antibodies in Myeloma: A Single Center Analysis
    Roberts, Danielle
    Scott, Sara
    Lonial, Sagar
    Dhodapkar, Madhav V.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S281 - S282
  • [9] Understanding Infection Risk with Anti-BCMA Bispecific Antibodies
    Garfall, Alfred L.
    Stadtmauer, Edward A.
    BLOOD CANCER DISCOVERY, 2023, 4 (06): : 427 - 429
  • [10] Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma
    Cliff, Edward R. Scheffer
    Reynolds, Gemma
    Popat, Rakesh
    Teh, Benjamin W.
    Kesselheim, Aaron S.
    Mohyuddin, Ghulam Rehman
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (10) : 1949 - +
12345